Open Orphan sets sights on €100m valuation
Open Orphan is targeting a valuation of €100 million in the next year after it completes the reverse takeover of drug services company Venn Life Sciences.
Independent journalism every day
With digital access you can read The Business Post whenever, wherever, and however you want.
- Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
- Breaking news, comment and analysis from the best Business Post writers seven days a week.
- Live blogs of major news events.
- Videos and podcasts from some of the industry's most respected journalists such as Michael Brennan, Susan Mitchell and Ian Guider.
- Access to The Business Post's extensive archive.